JEFFERY S. THOMPSON - Corporate Board Profile

Anika Therapeutics, Inc.

Filing Date	Source Excerpt
2011-04-28	Mr. Thompson joined Anika’s Board of Directors in January 2011. He did not receive compensation in 2010 as he joined after the fiscal year.
2012-04-25	Mr. Thompson joined Anika’s Board of Directors in January 2011. He serves on the Compensation Committee. The following table summarizes the compensation paid by the Company to non-employee Directors for the year ended December 31, 2011. Jeffery S. Thompson received $29,000 in fees earned or paid in cash and $59,281 in stock awards, totaling $88,281.
2013-04-23	Mr. Thompson joined Anika’s Board of Directors in January 2011. ... Mr. Thompson’s qualifications for membership on the Company’s Board include his prior experience in running a pharmaceutical company and his knowledge of the medical device industry. ... The current members of the Compensation Committee are Dr. Bower, as Chairperson, Mr. Thompson, and Mr. Wheeler. ... The following table summarizes the compensation paid by the Company to non-employee Directors for the year ended December 31, 2012. ... Jeffery S. Thompson Fees Earned or Paid in Cash $28,500, Stock Awards $29,994, Total $58,494.
2014-04-23	Mr. Thompson joined Anika’s Board of Directors in January 2011. Mr. Thompson’s qualifications for membership on the Company’s Board include his prior experience in running a pharmaceutical company and his knowledge of the medical device industry. The current members of the Compensation Committee are Dr. Bower, as Chairperson, Mr. Thompson, and Mr. Wheeler, each of whom is independent for purposes of NASDAQ listing standards and the SEC. The following table summarizes the compensation paid by the Company to non-employee Directors for the year ended December 31, 2013. Jeffery S. Thompson Fees Earned or Paid in Cash $31,000, Stock Awards $30,001, Total $61,001.
2015-04-23	Jeffery S. Thompson joined the Board of Directors in January 2011. He is a Partner with HealthEdge Investment Partners, LLC. Mr. Thompson was elected to the Audit Committee on February 18, 2015, and his service will commence on July 1, 2015. He serves on the Compensation Committee. The following table summarizes the compensation we paid to non-employee directors for the year ended December 31, 2014. Jeffery S. Thompson: Fees Paid in Cash $44,250, Stock Awards $59,973, Total $104,223.
2016-04-20	Jeffery S. Thompson joined the Board of Directors in January 2011. He serves on the Audit Committee and the Compensation Committee. For 2015, he received $49,500 in cash fees and $59,972 in stock awards, totaling $109,472.
2017-04-28	Jeffery S. Thompson joined the Board of Directors in January 2011. He is a Partner with HealthEdge Investment Partners, LLC (“HealthEdge”), a Tampa, Florida based private equity firm that provides strategic capital exclusively in the healthcare industry. Mr. Thompson currently serves as a director for various HealthEdge affiliated companies including AMC, Formulated Solutions, Santus, MNG Laboratories, Columbus Group, and Data Dimensions, LLC. Mr. Thompson also serves as a non-executive director for Sinclair Pharma, plc, a publicly traded, London-based, international aesthetic dermatology company. Prior to joining Anika, he served as President, Chief Executive Officer and Chairman of Advanced Bio-Technologies and Enaltus, HealthEdge portfolio companies specializing in skincare solutions. Mr. Thompson also served as a director and the Chief Operating Officer for Stiefel Laboratories, Inc. (“Stiefel”), an independent pharmaceutical company specializing in dermatology. Prior to his Chief Operating Officer role, he was Stiefel’s Senior Vice President of U.S. Business Services and President of Glades Pharmaceuticals. Earlier in his career, Mr. Thompson held sales and business management positions at Bausch & Lomb Pharmaceuticals and SmithKline Beecham. Mr. Thompson holds a B.S. in general science from the University of Pittsburgh. Mr. Thompson’s qualifications for membership on the Board include his prior experience in running a pharmaceutical company and his knowledge of the medical device industry, both of which provide the Board with product and business development perspectives and insights. He serves on the Audit Committee and the Compensation Committee.
2018-04-17	Jeffery S. Thompson joined the Board of Directors in January 2011. He serves on the Audit Committee and the Compensation Committee. The following table summarizes the compensation we paid to non-employee directors for 2017. Jeffery S. Thompson: Fees Earned or Paid in Cash ($) 57,000, Stock Awards ($) 99,959, Total ($) 156,959.
2019-04-25	Jeffery S. Thompson Anika Board Service ·Tenure: 8 years ·Committees: ○ Audit ○ Compensation ○ Governance and Nominating (Chair) INDEPENDENT Age: 53 Director Compensation Jeffery S. Thompson Fees Earned or Paid in Cash ($): 57,000 Stock Awards ($): 99,950 Total ($): 156,950
2020-04-29	Jeffery S. Thompson Age: 54 Director since 2011 Committees: Audit, Compensation, Governance and Nominating (Chair) 2019 Director Compensation: $201,369 Independent Director
2021-04-30	Jeffery S. Thompson Age: 55 Director since January 2011 Operating Partner, HealthEdge Investment Partners, LLC Independent Chair of the Board 2020 Director Compensation: Fees earned or paid in cash $78,310, Stock awards $174,999, Total $253,309
2022-04-27	Jeffery S. Thompson serves as Chair of the Board and does not serve on any standing committees. He is an Independent Director.
2023-05-01	Jeffery S. Thompson - Director since January 2011, Chair of the Board, Committees: Capital Allocation, Age: 57. Compensation: $261,676 in 2022.